Calmurid Cream

  • Name:

    Calmurid Cream

  • Company:
    info
  • Active Ingredients:

    Lactic Acid, Urea

  • Legal Category:

    Supply through pharmacy only

Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 04/12/17

files-icon(Click to Download)

XPIL

Summary of Product Characteristics last updated on medicines.ie: 1/12/2017
print

Print ViewKeyword Search SmPC

Galderma International S.A.S. c/o Galderma (U.K) Ltd.

Galderma (U

Company Products

Medicine NameActive Ingredients
Medicine Name Acnecide Gel 5% Active Ingredients Benzoyl Peroxide, hydrous
Medicine Name Azzalure Active Ingredients Botulinum Toxin Type A
Medicine Name Calmurid Cream Active Ingredients Lactic Acid, Urea
Medicine Name Calmurid HC Cream Active Ingredients Hydrocortisone, Lactic Acid, Urea
Medicine Name Curanail 5% w/v Medicated Nail Lacquer Active Ingredients Amorolfine Hydrochloride
Medicine Name Differin Cream 0.1% w/w Active Ingredients Adapalene
Medicine Name Differin Gel Active Ingredients Adapalene
Medicine Name Efracea capsules Active Ingredients Doxycycline monohydrate
Medicine Name Epiduo 0.1%/2.5% Gel Active Ingredients Adapalene, Benzoyl Peroxide
Medicine Name Etrivex 500 micrograms/g Shampoo Active Ingredients Clobetasol Propionate
Medicine Name Loceryl Nail Lacquer Active Ingredients Amorolfine Hydrochloride
Medicine Name Metvix Cream Active Ingredients Methyl Aminolevulinate Hydrochloride
Medicine Name Mirvaso 3mg/g Gel Active Ingredients brimonidine tartrate
Medicine Name Rozex Cream Active Ingredients Metronidazole
Medicine Name Rozex Gel Active Ingredients Metronidazole
Medicine Name Silkis Ointment Active Ingredients Calcitriol
Medicine Name Soolantra 10 mg/g Cream Active Ingredients Ivermectin
Medicine Name Tetralysal 300 Capsules Active Ingredients Lymecycline
1 - 0 of 18 items.Total: Infinity pages

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 4 December 2017 PIL

Reasons for updating

  • Change to section 3 - how to take/use
  • Change to section 6 - date of revision
  • Change to section 2 - what you need to know - contraindications

Updated on 4 December 2017 PIL

Reasons for updating

  • New PIL for new product

Updated on 1 December 2017 SmPC

Reasons for updating

  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 4.6 - Pregnancy and lactation
  • Change to section 4.8 - Undesirable effects
  • Change to section 10 - Date of revision of the text

Legal category: Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

Section 4.2 - Restructuring of existing information

Section 4.4 - Addition of warnings regarding contact with the eyes, surrounding areas, inflamed skin or open wounds, and use in renal impairment.

Section 4.5 - Addition of interaction with corticosteroids, dithranol and 5-fluorouracil

Section 4.6 - Addition of warning regarding use in breast-feeding.

Section 4.8 - Updated HPRA ADR reporting details

Section 10 - Updated revision of text date

​​

Updated on 1 December 2017 SmPC

Reasons for updating

  • New SmPC for new product

Legal category: Supply through pharmacy only

Updated on 28 November 2013 PIL

Reasons for updating

  • Addition of information on reporting a side effect.

Updated on 13 November 2013 SmPC

Reasons for updating

  • Change to Section 4.8 – Undesirable effects - how to report a side effect

Legal category: Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

Information about how to report side effects has been added to section 4.8.

Updated on 16 December 2009 SmPC

Reasons for updating

  • Change to section 1 - Name of medicinal product

Legal category: Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

The name of the product has been updated to encompass the strength and the pharmaceutical form.

Updated on 24 August 2009 PIL

Reasons for updating

  • Change due to user-testing of patient information

Updated on 24 June 2009 PIL

Reasons for updating

  • Change to packaging

Updated on 6 August 2008 PIL

Reasons for updating

  • Introduction of new pack/pack size

Updated on 6 August 2008 SmPC

Reasons for updating

  • Change to section 6.5 - Nature and contents of container

Legal category: Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

Addition of 30g pack size

Updated on 1 March 2007 PIL

Reasons for updating

  • Change to date of revision

Updated on 30 August 2006 SmPC

Reasons for updating

  • Change to section 7 - Marketing authorisation holder
  • Change to section 10 - Date of revision of the text

Legal category: Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

Section 7 - Change of office address from, Galderma House, Church Lane, Kings Langley, Hertfordshire, WD4 8JP to Meridien House, 69-71 Clarendon Road, Watford, Herts, WD17 1DS

Updated on 18 May 2005 PIL

Reasons for updating

  • Change of manufacturer
  • Change to date of revision

Updated on 9 August 2004 PIL

Reasons for updating

  • New PIL for medicines.ie

Updated on 21 April 2004 SmPC

Reasons for updating

  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 3 - Pharmaceutical form
  • Change to section 6.4 - Special precautions for storage
  • Change to section 6.6 - Special precautions for disposal and other handling
  • Change to section 9 - Date of renewal of authorisation
  • Change to section 10 - Date of revision of the text

Legal category: Supply through pharmacy only

Updated on 16 June 2003 SmPC

Reasons for updating

  • New SPC for medicines.ie

Legal category: Supply through pharmacy only